| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RIGEL PHARMACEUTICALS INC | Director | Common Stock | 100K | $114K | $1.14 | May 25, 2024 | Direct |
| SOLIGENIX, INC. | Director | Stock Option (Right to Buy) | 38.1K | Dec 15, 2023 | Direct | ||
| RIGEL PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 30K | May 25, 2024 | Direct | ||
| Astria Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14.1K | Jun 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ATXS | Astria Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 6, 2024 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 25, 2024 | 2 | $0 | 4 | May 29, 2024 | Director |
| SNGX | SOLIGENIX, INC. | Dec 15, 2023 | 1 | $0 | 4 | Dec 15, 2023 | Director |
| ATXS | Astria Therapeutics, Inc. | Jun 2, 2023 | 1 | $0 | 4 | Jun 6, 2023 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 26, 2023 | 2 | $0 | 4 | Jul 12, 2023 | Director |
| SNGX | SOLIGENIX, INC. | Nov 17, 2022 | 1 | $0 | 4 | Nov 21, 2022 | Director |
| ATXS | Astria Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4/A | Jun 21, 2022 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 20, 2022 | 2 | $0 | 4 | May 23, 2022 | Director |
| SNGX | SOLIGENIX, INC. | Sep 23, 2021 | 1 | $0 | 4 | Sep 24, 2021 | Director |
| ATXS | CATABASIS PHARMACEUTICALS INC | Jun 2, 2021 | 1 | $0 | 4 | Jun 2, 2021 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 19, 2021 | 2 | $0 | 4 | May 21, 2021 | Director |